Chief Executive Officer
Jeff is a serial healthcare entrepreneur with over 18 years of pharmaceutical experience. Before taking over as TrialScope CEO in 2018, Jeff served on the Company’s Board of Directors for more than two years.
Prior to TrialScope, Jeff was the founder of two successful healthcare technology companies, HeroLinx and Verilogue. HeroLinx is an online crowdsourcing platform for accelerating clinical trial awareness and patient recruiting. Verilogue, which was acquired by Publicis (PUB:FP), is the global leader in the capture and linguistic analysis of physician-patient exam room dialogues.
Jeff also previously served on the Board of Directors for iContracts, a SaaS compliance and revenue management company, and he remains an active angel investor and advisor to a half-dozen software and analytics companies.
Jeff holds a BS in Economics from the Wharton School at the University of Pennsylvania, and is the co-author of a method and system patent for analyzing the effectiveness of marketing strategies.